# Tolvaptan

## Samsca 15mg

| 藥物代碼 | OSAM |
| :--- | :--- |
| 適應症 | Clinically significant hypervolemic & euvolemic hyponatremia including patients w/ heart failure & syndrome of inappropriate antidiuretic hormone \(SIADH\). |
| 副作用 | Thirst, dry mouth, pollakiuria or polyuria, asthenia, constipation, hyperglycemia, pyrexia & anorexia. |
| 禁忌 | Urgent need to raise serum Na acutely; inability to sense or appropriately respond to thirst; hypovolemic hyponatremia; strong CYP3A inhibitors \(eg clarithromycin, ketoconazole, itraconazole, ritonavir, indinavir, nelfinavir, saquinavir, nefazodone & telithromycin\); anuric patients. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult: Initially 15 mg once daily, may be increased to 30 mg once daily after at least 24 hr. Max: 60 mg once daily. Max duration of therapy: Not &gt;30 days. |
| 肝功能異常 | 無需調整劑量  因臨床資料有限，使用於重度肝功能不全\(Child-Pugh classes C\)的病人必須特別小心。 Tolvaptan 避免使用於有肝疾病\(underlying liver disease\)的病人。 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

